Lupisit DM 10mg/1000mg/100mg Tablet ER

Lupisit DM is a once-daily extended-release tablet containing a combination of three powerful antidiabetic medications: Dapagliflozin, Metformin, and Sitagliptin. This unique formulation provides comprehensive control of blood sugar levels in patients with type 2 diabetes.

Dapagliflozin (10mg): A sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes glucose excretion through the kidneys, reducing blood sugar levels.
Metformin (1000mg): A first-line treatment for type 2 diabetes, lowering blood sugar by reducing hepatic glucose production and improving insulin sensitivity.
Sitagliptin (100mg): A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances the action of incretin hormones, further improving insulin secretion and decreasing glucagon levels.

Lupisit DM's extended-release formula provides consistent blood sugar management without frequent dosing. The combination of these three medications offers a comprehensive approach to managing type 2 diabetes, making it suitable for patients seeking improved glycemic control with convenient once-daily administration.

Note: This product description is for informational purposes only and should not be interpreted as medical advice. Consult your healthcare professional for proper diagnosis and treatment of diabetes.